No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Dermatologic Agents / administration & dosage*
-
Dermatologic Agents / adverse effects
-
Drug Administration Schedule
-
Drug Substitution
-
Female
-
Humans
-
Injections, Subcutaneous
-
Interleukin-17 / antagonists & inhibitors
-
Interleukin-17 / immunology
-
Male
-
Middle Aged
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
IL17A protein, human
-
Interleukin-17
-
ixekizumab
-
secukinumab